首页> 外国专利> Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals

Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals

机译:用于增强温血动物免疫,抗炎,抗肿瘤和DNA修复过程的植物钩藤属生物活性成分的水溶性提取物的制备方法和组成

摘要

A method for isolating the bioactive component of the water-soluble extract of Uncaria tomentosa known as C-MED-100®, comprising (i) precipitating the spray drying carrier from C-MED-100®; (ii) using the resulting C-MED-100® to obtain a spotting mixture for thin layer chromatography (TLC); (iii) spotting the C-MED-100® spotting mixture on pre-run TLC plates and eluting the plates to obtain the fluorescing band with Rf=0.2-0.3; (iv) scraping off the Rf=0.2-0.3 band, eluting it in ammonia and freeze drying the eluted band to form a powder; and (v) extracting the powder with methanol to remove solubilized silica gel, concentrating the methanol solution and crystalizing the concentrated solution to obtain the bioactive component. The isolated bioactive component is a quinic acid analog, preferably quinic acid lactone. A pharmaceutical composition comprising a pharmaceutically effective amount of the bioactive component and a nontoxic inert carrier or diluent. The bioactive component may be used to enhance immune competency, treat disorders associated with the immune system, inhibit the inflammatory response, treat disorders associated with the inflammatory response, enhance the anti-tumor response, and treat disorders associated with the response to tumor formation and growth, all in mammals.
机译:一种分离毛白云杉水溶性提取物的生物活性成分的方法,该方法称为C-MED-100®,包括:(i)从C-MED-100®中沉淀出喷雾干燥载体; (ii)使用所得的C-MED-100®获得薄层色谱法(TLC)的斑点混合物; (iii)在预运行的TLC板上点样C-MED-100®点样混合物,并洗脱板以获得R f = 0.2-0.3的荧光带; (iv)刮掉R f = 0.2-0.3带,用氨水洗脱并冷冻干燥洗脱带,形成粉末; (v)用甲醇萃取粉末以除去溶解的硅胶,浓缩甲醇溶液并使浓缩的溶液结晶以获得生物活性组分。分离的生物活性组分是奎尼酸类似物,优选奎尼酸内酯。药物组合物,其包含药学有效量的生物活性组分和无毒惰性载体或稀释剂。生物活性成分可用于增强免疫能力,治疗与免疫系统有关的疾病,抑制炎症反应,治疗与炎症反应有关的疾病,增强抗肿瘤反应以及治疗与对肿瘤形成和形成的反应有关的疾病。生长,都在哺乳动物中。

著录项

  • 公开/公告号US7579023B2

    专利类型

  • 公开/公告日2009-08-25

    原文格式PDF

  • 申请/专利权人 RONALD W. PERO;

    申请/专利号US20050270235

  • 发明设计人 RONALD W. PERO;

    申请日2005-11-09

  • 分类号A61K31/34;A61K31/05;

  • 国家 US

  • 入库时间 2022-08-21 19:32:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号